23
Participants
Start Date
March 12, 2004
Primary Completion Date
May 2, 2008
Study Completion Date
June 21, 2010
Midomafetamine HCl
125 mg of midomafetamine HCl followed by a supplemental half-dose of 62.5 mg of midomafetamine HCl
Lactose placebo pill
125 mg followed by a supplemental half-dose of 62.5 mg
Therapy
Non-directive therapy provided by a team of two co-therapists
Offices of Michael Mithoefer MD, Mt. Pleasant
Lead Sponsor
Lykos Therapeutics
INDUSTRY